Independent research for educational purposes only  ·  Not investment advice  ·  Prices as of 13 Nov 2026 close
“...pleasure and pain, they come and go and don't last... bear them patiently”
—Gita
Pathos InvestmentsEquity Research
Research  ›  Coverage  ›  MU
Research Note · Initiation · Value Lens

Micron Technology, Inc. (MU)

Published 30 September 2026NASDAQ: MUDRAM, HBM & NAND memoryFiscal year ends ~1 SeptemberOne-page fact sheetCongress trades in MU →
Price · 13 Nov 26$778.31
Base 5-yr value*~$1,221
5-yr range*$831–1,745

I.Executive Summary

Micron is the largest U.S. maker of memory chips: DRAM (including the high-bandwidth memory, or HBM, stacked next to AI accelerators) and NAND flash. On 30 September 2026 it reported a record fiscal 2026 (53 weeks to 3 September 2026). Revenue rose 256% to $133.2 billion, GAAP operating margin was 74.6%, net income was $85.0 billion and diluted EPS was $74.33. Management guides first-quarter fiscal 2027 revenue to $61.5 billion ± $1.5 billion at a gross margin of about 86%. These results are unaudited until the 10-K is filed.

FY26 Revenue$133.2B+256% year on year
FY26 Op. margin74.6%FY15–25 average: 17.5%
FY26 Adj. free cash flow$62.3BFY15–25 total: $15.2B
Book value / share$122.52Price = 6.3× book

On this year's numbers the stock looks inexpensive: 10.5× trailing GAAP earnings and 4.4× consensus fiscal 2027 earnings. A value investor should be careful with that arithmetic. Memory is one of the most cyclical industries in public markets. In the eleven years before fiscal 2026, Micron's operating margin ranged from −37% (FY2023) to 49% (FY2018) and averaged 17.5%. Cumulative free cash flow over those eleven years was $15.2 billion, less than a third of the $48.9 billion of cumulative net income, because the business has to reinvest about 37% of revenue in fabs and equipment. Measured against book value, the stock trades at 6.3×. At fiscal year-ends from 2015 to 2025 the ratio ranged from 1.2× to 2.5×.

Micron is executing brilliantly at the top of the strongest memory upcycle on record. Today's low multiple is the market's bet that peak earnings will fall. Our projection values a mid-cycle level of earnings, 40–60% of the fiscal 2028 consensus, at 10–14×; on that basis the base case implies a mid-single-digit annual return.

Our illustrative five-year projection takes the fiscal 2027–fiscal 2028 consensus as Years 1–2, then applies a mid-cycle EPS level (a stated share of the fiscal 2028 consensus) and an exit P/E of 10.0×–14.0×; the base case is the midpoint of the bear–bull range. That gives Year-5 values of $831 (bear), $1,221 (base) and $1,745 (bull), against today's $778.31: an implied return of about +9.4% a year in the base case (+1.3% to +17.5%). Discounted at 10% a year, the base case is worth $758 today, −3% versus the price. Today's price enters only the implied return; the Year-5 values change only when earnings estimates or the stated assumptions do. Evidence: Weak–moderate. Consensus EPS is moderately well supported (36 analysts), but the mid-cycle share of peak earnings is a judgement. *All values are Pathos's illustrative estimates for educational purposes, not price targets or recommendations.

II.Business Overview

What it sells. DRAM made up 76% of fiscal 2025 revenue ($28.6B of $37.4B) and 77% in the first nine months of fiscal 2026. NAND flash made up most of the rest. HBM is a 3D stack of DRAM dies that sits next to GPUs and other AI accelerators, and it is Micron's most strategic product. The FY2025 10-K says HBM3E 12-high made up most of HBM shipments in the fourth quarter of fiscal 2025 and that HBM4 samples had gone to multiple key customers. On the June 2026 call management said Micron had already shipped more than $1B of HBM4 revenue. Micron does not disclose total HBM revenue in the filings we reviewed. CNBC describes it as the only U.S.-based HBM maker and the smallest of the three HBM suppliers by share, behind SK hynix and Samsung.

How it reports. Since fiscal 2025 there are four business units. Fourth-quarter fiscal 2026 revenue was: Cloud Memory (CMBU: hyperscalers, plus HBM for all data-center customers) $16.3B, Core Data Center (CDBU) $18.0B, Mobile & Client (MCBU) $13.1B, and Automotive & Embedded (AEBU) $6.8B.

Who buys it. About half of revenue has come from the top ten customers in each of the last three years. One customer accounted for 17% of fiscal 2025 revenue, mainly in CMBU, and about half of fiscal 2025 revenue came from the data-center end market. Since May 2023, China's Cyberspace Administration has barred operators of critical information infrastructure in China from buying Micron products.

Competition. Micron's 10-K names Samsung, SK hynix, Kioxia, Sandisk, CXMT and YMTC. DRAM is effectively a three-player market (Samsung, SK hynix, Micron) with Chinese entrants growing, and all three leaders are adding capacity.

What is new: Strategic Customer Agreements. In the third and fourth quarters of fiscal 2026 Micron signed multi-year take-or-pay agreements with binding volume commitments. The Q3 10-Q describes them: pricing on most is either fixed or held between a floor and a ceiling. For the largest agreements, the ceiling is roughly the market price of the second calendar quarter of 2026. Management expects these agreements to produce gross margins "well above our peak quarterly margins in any past cycle" even at floor prices. It expected about $22B of deposits and related financial commitments from the agreements signed to date, roughly $18B of it in cash. Micron received $12.7B of customer deposits in fiscal 2026, and non-current customer contract liabilities reached $12.9B at year-end. The individual contract terms, and the share of volume they cover, are not disclosed.

Conventions used in this noteMicron's fiscal year ends on the Thursday closest to 31 August. FY2026 ran 53 weeks from 29 August 2025 to 3 September 2026. FY2026 annual and fourth-quarter figures come from the 30 September 2026 earnings release; the audited FY2026 10-K (filed 9 October 2026) reports the same full-year revenue ($133.19B) and diluted EPS ($74.33). Earlier years come from audited 10-K data. Dollar figures are US$, and "B" and "M" mean billions and millions. The share price of $778.31 is the 13 November 2026 close.

III.Share Price & Valuation Multiples

Price as of Nasdaq close, 13 Nov 2026 · Fundamentals: Q4 FY2026 release and FY2026 10-K
MetricValueBasis
Share price$778.31Close, 13 Nov 2026
52-week range$192.59 – $1,255.00Low 21 Nov 2025 · high 25 Jun 2026. One-year change +228% (13 Nov 2025 close $236.95)
Market capitalisation$879.0B1,129.4M shares (10-Q cover, 17 Jun 2026) × $778.31
Enterprise value$810.8BMkt cap + $5.18B debt − $73.45B cash & marketable investments
P/E, trailing (GAAP)10.5×FY26 diluted EPS $74.33 (non-GAAP $75.52: 11.7×)
P/E, forward4.4×FY27 consensus EPS $176.50 (36 analysts, Yahoo, 15 Nov 2026; likely non-GAAP)
P/E on Q1 FY27 guidance, annualized5.1×GAAP EPS guide $37.84 × 4 = $151.36
P/E on FY15–FY25 average EPS205×Average diluted EPS $3.80 over eleven years (a through-cycle view)
EV / EBITDA6.6×FY26 op. income $99.34B + D&A $9.50B
Price / Sales6.6×FY26 revenue $133.19B (EV/Sales 6.1×)
Price / Book6.3×Equity $138.38B; $122.52 per share. FY15–FY25 year-end range 1.2×–2.5× (median 1.7×)
Price / Free cash flow14.1×FY26 adjusted FCF $62.31B (OCF less capex net of $3.3B government incentives)
Dividend yield0.08%$0.15 quarterly, declared 30 Sep 2026

These multiples tell two stories depending on the denominator. On peak-cycle earnings Micron screens cheap. On through-cycle earnings (the eleven-year average EPS of $3.80, or $9.68 including fiscal 2026) and on book value, it looks very expensive against its own history. The fiscal 2027 consensus is as compiled by Yahoo Finance on 15 November 2026, after the Q4 release and the Q1 guide. For context only (not an input to our work), the mean analyst price target compiled by Yahoo Finance was $1,561.91 (45 analysts). Our enterprise value does not subtract the $12.9B of customer deposits. Those are cash Micron holds against future deliveries, effectively a debt-like claim.

IV.Through-Cycle Financial Record

Annual revenue, US$ billions, with operating marginFY2015–FY2026 · FY26 unaudited
$40B$80B$120B 16.212.420.330.423.421.427.730.815.525.137.4133 FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26 OM 18%OM 1%OM 29%OM 49%OM 32%OM 14%OM 23%OM 32%OM -37%OM 5%OM 26%OM 75%

Source: Micron Forms 10-K (SEC XBRL data) for FY2015–FY2025; FY2026 from the 30 Sep 2026 earnings release (unaudited, 53 weeks). OM = GAAP operating margin.

US$MRevenueGross marginOp. marginNet incomeDiluted EPSOp. CFCapexFCF
FY201516,19232.2%18.5%2,899$2.475,208(4,021)1,187
FY201612,39920.2%1.4%(276)($0.27)3,168(5,817)(2,649)
FY201720,32241.5%28.9%5,089$4.418,153(4,734)3,419
FY201830,39158.9%49.3%14,135$11.5117,400(8,879)8,521
FY201923,40645.7%31.5%6,313$5.5113,189(9,780)3,409
FY202021,43530.6%14.0%2,687$2.378,306(8,223)83
FY202127,70537.6%22.7%5,861$5.1412,468(10,030)2,438
FY202230,75845.2%31.5%8,687$7.7515,181(12,067)3,114
FY202315,540−9.1%−37.0%(5,833)($5.34)1,559(7,676)(6,117)
FY202425,11122.4%5.2%778$0.708,507(8,386)121
FY202537,37839.8%26.1%8,539$7.5917,525(15,857)1,668
FY2026*133,18880.7%74.6%84,969$74.3389,675(30,712)58,963
FY15–25 average23,69433.2%17.5%4,444$3.8010,060(8,679)1,381
Source: Micron 10-K XBRL data; *FY2026 from the unaudited earnings release. Capex = gross purchases of property, plant & equipment (before government incentives); FCF = operating cash flow − capex (Pathos calculation; Micron's "adjusted FCF" nets incentives and was $62,308M in FY26). Averages are simple averages of the annual figures (margins averaged year by year).

Fiscal 2026 by quarter: the upcycle accelerates

US$ millionsQ1 (Nov 25)Q2 (Feb 26)Q3 (May 26)Q4 (Sep 26)*Q1 FY27 guide
Revenue13,64323,86041,45654,22961,500 ± 1,500
Gross margin56.0%74.4%84.6%86.8%~86.0%
Operating margin45.0%67.6%80.4%80.7%n/a
Net income5,24013,78528,24337,701n/a
Diluted EPS$4.60$12.07$24.67$32.87$37.84 ± $1.00
Source: Forms 10-Q (Q1–Q3 FY2026); *Q4 (14 weeks) and guidance from the 30 Sep 2026 release (unaudited). Q4 figures are full year less nine months. Guidance is GAAP.

Quarterly revenue quadrupled in a year (Q4 FY25 was $11.3B at a 44.7% gross margin), and gross margin went from 45% to 87%. Nothing in Micron's history resembles this: the previous peak quarterly gross margins came in fiscal 2018, when the full-year figure was 58.9%. Management attributes it to AI-driven demand against structurally constrained supply. The Q4 LSEG consensus was $31.61 EPS on $51.07B of revenue (per CNBC), which Micron beat on both lines.

Quarterly revenue, net income & trailing P/EQ1 FY22–Q4 FY26 · 20 quarters
−20 0 20 40 60 $ bn 0× 50× 100× 150× P/E Mar ’22 Sep ’22 Mar ’23 Aug ’23 Feb ’24 Aug ’24 Feb ’25 Aug ’25 Feb ’26 Sep ’26 Q1 FY22 (quarter ended 2 Dec 2021): revenue $7.7bn; net income $2.3bn; P/E 12.8× (close $82.88 on 2 Dec 2021 ÷ TTM EPS $6.48) Q2 FY22 (quarter ended 3 Mar 2022): revenue $7.8bn; net income $2.3bn; P/E 11.2× (close $89.18 on 3 Mar 2022 ÷ TTM EPS $7.95) Q3 FY22 (quarter ended 2 Jun 2022): revenue $8.6bn; net income $2.6bn; P/E 8.6× (close $75.37 on 2 Jun 2022 ÷ TTM EPS $8.77) Q4 FY22 (quarter ended 1 Sep 2022): revenue $6.6bn; net income $1.5bn; P/E 7.4× (close $57.31 on 1 Sep 2022 ÷ TTM EPS $7.75) Q1 FY23 (quarter ended 1 Dec 2022): revenue $4.1bn; net income $-0.2bn; P/E 10.0× (close $55.49 on 1 Dec 2022 ÷ TTM EPS $5.53) Q2 FY23 (quarter ended 2 Mar 2023): revenue $3.7bn; net income $-2.3bn; P/E 40.0× (close $56.43 on 2 Mar 2023 ÷ TTM EPS $1.41) Q3 FY23 (quarter ended 1 Jun 2023): revenue $3.8bn; net income $-1.9bn; P/E not shown (TTM EPS negative) Q4 FY23 (quarter ended 31 Aug 2023): revenue $4.0bn; net income $-1.4bn; P/E not shown (TTM EPS negative) Q1 FY24 (quarter ended 30 Nov 2023): revenue $4.7bn; net income $-1.2bn; P/E not shown (TTM EPS negative) Q2 FY24 (quarter ended 29 Feb 2024): revenue $5.8bn; net income $0.8bn; P/E not shown (TTM EPS negative) Q3 FY24 (quarter ended 30 May 2024): revenue $6.8bn; net income $0.3bn; P/E not shown (TTM EPS negative) Q4 FY24 (quarter ended 29 Aug 2024): revenue $7.8bn; net income $0.9bn; P/E 138.5× (close $95.57 on 29 Aug 2024 ÷ TTM EPS $0.69) Q1 FY25 (quarter ended 28 Nov 2024): revenue $8.7bn; net income $1.9bn; P/E 28.2× (close $98.20 on 27 Nov 2024 ÷ TTM EPS $3.48) Q2 FY25 (quarter ended 27 Feb 2025): revenue $8.1bn; net income $1.6bn; P/E 22.0× (close $91.82 on 27 Feb 2025 ÷ TTM EPS $4.18) Q3 FY25 (quarter ended 29 May 2025): revenue $9.3bn; net income $1.9bn; P/E 17.4× (close $96.80 on 29 May 2025 ÷ TTM EPS $5.56) Q4 FY25 (quarter ended 28 Aug 2025): revenue $11.3bn; net income $3.2bn; P/E 16.1× (close $122.00 on 28 Aug 2025 ÷ TTM EPS $7.60) Q1 FY26 (quarter ended 27 Nov 2025): revenue $13.6bn; net income $5.2bn; P/E 21.9× (close $230.26 on 26 Nov 2025 ÷ TTM EPS $10.53) Q2 FY26 (quarter ended 26 Feb 2026): revenue $23.9bn; net income $13.8bn; P/E 19.6× (close $415.56 on 26 Feb 2026 ÷ TTM EPS $21.19) Q3 FY26 (quarter ended 28 May 2026): revenue $41.5bn; net income $28.2bn; P/E 20.9× (close $923.52 on 28 May 2026 ÷ TTM EPS $44.18) Q4 FY26 (quarter ended 3 Sep 2026): revenue $54.2bn; net income $37.7bn; P/E 12.9× (close $958.16 on 3 Sep 2026 ÷ TTM EPS $74.27) RevenueNet incomeNet lossP/E, TTM (right) −20 0 20 40 60 $ bn 0× 50× 100× 150× P/E Sep ’22 Aug ’23 Aug ’24 Aug ’25 Sep ’26 Q1 FY22 (quarter ended 2 Dec 2021): revenue $7.7bn; net income $2.3bn; P/E 12.8× (close $82.88 on 2 Dec 2021 ÷ TTM EPS $6.48) Q2 FY22 (quarter ended 3 Mar 2022): revenue $7.8bn; net income $2.3bn; P/E 11.2× (close $89.18 on 3 Mar 2022 ÷ TTM EPS $7.95) Q3 FY22 (quarter ended 2 Jun 2022): revenue $8.6bn; net income $2.6bn; P/E 8.6× (close $75.37 on 2 Jun 2022 ÷ TTM EPS $8.77) Q4 FY22 (quarter ended 1 Sep 2022): revenue $6.6bn; net income $1.5bn; P/E 7.4× (close $57.31 on 1 Sep 2022 ÷ TTM EPS $7.75) Q1 FY23 (quarter ended 1 Dec 2022): revenue $4.1bn; net income $-0.2bn; P/E 10.0× (close $55.49 on 1 Dec 2022 ÷ TTM EPS $5.53) Q2 FY23 (quarter ended 2 Mar 2023): revenue $3.7bn; net income $-2.3bn; P/E 40.0× (close $56.43 on 2 Mar 2023 ÷ TTM EPS $1.41) Q3 FY23 (quarter ended 1 Jun 2023): revenue $3.8bn; net income $-1.9bn; P/E not shown (TTM EPS negative) Q4 FY23 (quarter ended 31 Aug 2023): revenue $4.0bn; net income $-1.4bn; P/E not shown (TTM EPS negative) Q1 FY24 (quarter ended 30 Nov 2023): revenue $4.7bn; net income $-1.2bn; P/E not shown (TTM EPS negative) Q2 FY24 (quarter ended 29 Feb 2024): revenue $5.8bn; net income $0.8bn; P/E not shown (TTM EPS negative) Q3 FY24 (quarter ended 30 May 2024): revenue $6.8bn; net income $0.3bn; P/E not shown (TTM EPS negative) Q4 FY24 (quarter ended 29 Aug 2024): revenue $7.8bn; net income $0.9bn; P/E 138.5× (close $95.57 on 29 Aug 2024 ÷ TTM EPS $0.69) Q1 FY25 (quarter ended 28 Nov 2024): revenue $8.7bn; net income $1.9bn; P/E 28.2× (close $98.20 on 27 Nov 2024 ÷ TTM EPS $3.48) Q2 FY25 (quarter ended 27 Feb 2025): revenue $8.1bn; net income $1.6bn; P/E 22.0× (close $91.82 on 27 Feb 2025 ÷ TTM EPS $4.18) Q3 FY25 (quarter ended 29 May 2025): revenue $9.3bn; net income $1.9bn; P/E 17.4× (close $96.80 on 29 May 2025 ÷ TTM EPS $5.56) Q4 FY25 (quarter ended 28 Aug 2025): revenue $11.3bn; net income $3.2bn; P/E 16.1× (close $122.00 on 28 Aug 2025 ÷ TTM EPS $7.60) Q1 FY26 (quarter ended 27 Nov 2025): revenue $13.6bn; net income $5.2bn; P/E 21.9× (close $230.26 on 26 Nov 2025 ÷ TTM EPS $10.53) Q2 FY26 (quarter ended 26 Feb 2026): revenue $23.9bn; net income $13.8bn; P/E 19.6× (close $415.56 on 26 Feb 2026 ÷ TTM EPS $21.19) Q3 FY26 (quarter ended 28 May 2026): revenue $41.5bn; net income $28.2bn; P/E 20.9× (close $923.52 on 28 May 2026 ÷ TTM EPS $44.18) Q4 FY26 (quarter ended 3 Sep 2026): revenue $54.2bn; net income $37.7bn; P/E 12.9× (close $958.16 on 3 Sep 2026 ÷ TTM EPS $74.27) RevenueNet incomeNet lossP/E (right)

Bars: quarterly revenue and net income, US$ billions. Line: trailing P/E = closing share price at quarter-end ÷ trailing-12-month diluted EPS (sum of the last four quarters; fiscal Q4 derived as full-year minus nine-month figures). Gaps in the line: no P/E where trailing EPS was negative (Q3 FY23–Q3 FY24). Both axes share zero; the P/E scale extends below 0× only to make room for net-loss bars (P/E is never plotted below zero). Sources: Form 10-Q/10-K data via SEC XBRL company facts and the Q4 FY2026 earnings release (Form 8-K); Yahoo Finance price history. Hover over a quarter for exact values.

Total tangible book valueQ1 FY22–Q4 FY26 · 20 quarters
0 50 100 150 $ bn $137.2bn Mar ’22 Sep ’22 Mar ’23 Aug ’23 Feb ’24 Aug ’24 Feb ’25 Aug ’25 Feb ’26 Sep ’26 Q1 FY22 (2 Dec 2021): tangible book value $44.3bn (equity $45.9bn − goodwill $1.2bn − other intangibles $0.3bn); per share $39.58 on 1,120M shares Q2 FY22 (3 Mar 2022): tangible book value $46.2bn (equity $47.8bn − goodwill $1.2bn − other intangibles $0.4bn); per share $41.33 on 1,118M shares Q3 FY22 (2 Jun 2022): tangible book value $47.6bn (equity $49.3bn − goodwill $1.2bn − other intangibles $0.4bn); per share $43.11 on 1,105M shares Q4 FY22 (1 Sep 2022): tangible book value $48.3bn (equity $49.9bn − goodwill $1.2bn − other intangibles $0.4bn); per share $44.11 on 1,094M shares Q1 FY23 (1 Dec 2022): tangible book value $47.6bn (equity $49.3bn − goodwill $1.2bn − other intangibles $0.4bn); per share $43.68 on 1,091M shares Q2 FY23 (2 Mar 2023): tangible book value $45.6bn (equity $47.3bn − goodwill $1.2bn − other intangibles $0.4bn); per share $41.70 on 1,094M shares Q3 FY23 (1 Jun 2023): tangible book value $43.7bn (equity $45.4bn − goodwill $1.3bn − other intangibles $0.4bn); per share $39.95 on 1,095M shares Q4 FY23 (31 Aug 2023): tangible book value $42.6bn (equity $44.1bn − goodwill $1.1bn − other intangibles $0.4bn); per share $38.77 on 1,098M shares Q1 FY24 (30 Nov 2023): tangible book value $41.3bn (equity $42.9bn − goodwill $1.1bn − other intangibles $0.4bn); per share $37.43 on 1,104M shares Q2 FY24 (29 Feb 2024): tangible book value $42.3bn (equity $43.9bn − goodwill $1.1bn − other intangibles $0.4bn); per share $38.22 on 1,107M shares Q3 FY24 (30 May 2024): tangible book value $42.7bn (equity $44.2bn − goodwill $1.1bn − other intangibles $0.4bn); per share $38.47 on 1,109M shares Q4 FY24 (29 Aug 2024): tangible book value $43.6bn (equity $45.1bn − goodwill $1.1bn − other intangibles $0.4bn); per share $39.28 on 1,109M shares Q1 FY25 (28 Nov 2024): tangible book value $45.2bn (equity $46.8bn − goodwill $1.1bn − other intangibles $0.4bn); per share $40.60 on 1,114M shares Q2 FY25 (27 Feb 2025): tangible book value $47.1bn (equity $48.6bn − goodwill $1.1bn − other intangibles $0.4bn); per share $42.09 on 1,118M shares Q3 FY25 (29 May 2025): tangible book value $49.2bn (equity $50.7bn − goodwill $1.1bn − other intangibles $0.4bn); per share $43.94 on 1,119M shares Q4 FY25 (28 Aug 2025): tangible book value $52.6bn (equity $54.2bn − goodwill $1.1bn − other intangibles $0.5bn); per share $46.85 on 1,122M shares Q1 FY26 (27 Nov 2025): tangible book value $57.2bn (equity $58.8bn − goodwill $1.1bn − other intangibles $0.5bn); per share $50.79 on 1,126M shares Q2 FY26 (26 Feb 2026): tangible book value $70.8bn (equity $72.5bn − goodwill $1.1bn − other intangibles $0.5bn); per share $62.80 on 1,128M shares Q3 FY26 (28 May 2026): tangible book value $99.1bn (equity $100.7bn − goodwill $1.1bn − other intangibles $0.5bn); per share $87.78 on 1,129M shares Q4 FY26 (3 Sep 2026): tangible book value $137.2bn (equity $138.4bn − goodwill $1.1bn); per share $121.33 on 1,131M shares Total tangible book value 0 50 100 150 $ bn $137.2bn Sep ’22 Aug ’23 Aug ’24 Aug ’25 Sep ’26 Q1 FY22 (2 Dec 2021): tangible book value $44.3bn (equity $45.9bn − goodwill $1.2bn − other intangibles $0.3bn); per share $39.58 on 1,120M shares Q2 FY22 (3 Mar 2022): tangible book value $46.2bn (equity $47.8bn − goodwill $1.2bn − other intangibles $0.4bn); per share $41.33 on 1,118M shares Q3 FY22 (2 Jun 2022): tangible book value $47.6bn (equity $49.3bn − goodwill $1.2bn − other intangibles $0.4bn); per share $43.11 on 1,105M shares Q4 FY22 (1 Sep 2022): tangible book value $48.3bn (equity $49.9bn − goodwill $1.2bn − other intangibles $0.4bn); per share $44.11 on 1,094M shares Q1 FY23 (1 Dec 2022): tangible book value $47.6bn (equity $49.3bn − goodwill $1.2bn − other intangibles $0.4bn); per share $43.68 on 1,091M shares Q2 FY23 (2 Mar 2023): tangible book value $45.6bn (equity $47.3bn − goodwill $1.2bn − other intangibles $0.4bn); per share $41.70 on 1,094M shares Q3 FY23 (1 Jun 2023): tangible book value $43.7bn (equity $45.4bn − goodwill $1.3bn − other intangibles $0.4bn); per share $39.95 on 1,095M shares Q4 FY23 (31 Aug 2023): tangible book value $42.6bn (equity $44.1bn − goodwill $1.1bn − other intangibles $0.4bn); per share $38.77 on 1,098M shares Q1 FY24 (30 Nov 2023): tangible book value $41.3bn (equity $42.9bn − goodwill $1.1bn − other intangibles $0.4bn); per share $37.43 on 1,104M shares Q2 FY24 (29 Feb 2024): tangible book value $42.3bn (equity $43.9bn − goodwill $1.1bn − other intangibles $0.4bn); per share $38.22 on 1,107M shares Q3 FY24 (30 May 2024): tangible book value $42.7bn (equity $44.2bn − goodwill $1.1bn − other intangibles $0.4bn); per share $38.47 on 1,109M shares Q4 FY24 (29 Aug 2024): tangible book value $43.6bn (equity $45.1bn − goodwill $1.1bn − other intangibles $0.4bn); per share $39.28 on 1,109M shares Q1 FY25 (28 Nov 2024): tangible book value $45.2bn (equity $46.8bn − goodwill $1.1bn − other intangibles $0.4bn); per share $40.60 on 1,114M shares Q2 FY25 (27 Feb 2025): tangible book value $47.1bn (equity $48.6bn − goodwill $1.1bn − other intangibles $0.4bn); per share $42.09 on 1,118M shares Q3 FY25 (29 May 2025): tangible book value $49.2bn (equity $50.7bn − goodwill $1.1bn − other intangibles $0.4bn); per share $43.94 on 1,119M shares Q4 FY25 (28 Aug 2025): tangible book value $52.6bn (equity $54.2bn − goodwill $1.1bn − other intangibles $0.5bn); per share $46.85 on 1,122M shares Q1 FY26 (27 Nov 2025): tangible book value $57.2bn (equity $58.8bn − goodwill $1.1bn − other intangibles $0.5bn); per share $50.79 on 1,126M shares Q2 FY26 (26 Feb 2026): tangible book value $70.8bn (equity $72.5bn − goodwill $1.1bn − other intangibles $0.5bn); per share $62.80 on 1,128M shares Q3 FY26 (28 May 2026): tangible book value $99.1bn (equity $100.7bn − goodwill $1.1bn − other intangibles $0.5bn); per share $87.78 on 1,129M shares Q4 FY26 (3 Sep 2026): tangible book value $137.2bn (equity $138.4bn − goodwill $1.1bn); per share $121.33 on 1,131M shares Total tangible book value

Total tangible book value, US$ billions = shareholders’ equity minus goodwill and other intangible assets, at quarter-end. Q4 FY2026 uses the unaudited earnings release: intangible assets are not shown separately there ($0.5bn at 28 May 2026), so only goodwill is deducted. Source: balance sheets in Forms 10-Q/10-K via SEC XBRL company facts. Hover over a quarter for the components and the value per share.

V.Capital Intensity & Earnings Quality

Capital expenditure as a share of revenueFY2015–FY2026 · gross PP&E purchases
20%40%60% 25%47%23%29%42%38%36%39%49%33%42%23% FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26 FY15–25 average 36.6%

Source: Micron 10-K XBRL data and 30 Sep 2026 release; Pathos calculation. The dashed line is the FY2015–FY2025 average (36.6%).

Memory is a capital race. To keep shrinking its cost per bit and to add wafers, Micron spent on average 36.6% of revenue on capex from fiscal 2015 to 2025, against depreciation of about 24% of revenue. That gap is why accounting profits have historically turned into much less free cash: $15.2B of FCF against $48.9B of net income over those eleven years (31% conversion). Fiscal 2026 looks very different only because revenue quadrupled. Capex of $30.7B was 23% of revenue.

  • Capex is going up, not down. Micron estimated fiscal 2026 net capex at about $27B (actual: $27.37B). On its June 2026 earnings call management said it expects net capex in each quarter of fiscal 2027 to be above the fiscal fourth-quarter level (which came in at $10.77B), which implies more than $43B for the year. It also guided fiscal 2027 operating expenses about $1B higher. Projects include a new Boise, Idaho DRAM fab (first wafer output mid-calendar 2027), a second Boise fab (output late 2028), the first of up to four fabs in Clay, New York (supply from 2030), an HBM packaging plant in Singapore (capacity from 1H calendar 2027), a fab bought from PSMC in Tongluo, Taiwan in March 2026 for $1.8B (shipments from mid-2027), and assembly and test in Gujarat, India.
  • Subsidies help. CHIPS Act grants of up to $6.4B and a 35% U.S. investment tax credit reduce the net cost. Micron received $3.3B of incentives in fiscal 2026. The grants carry conditions, including limits on share buybacks, and can be clawed back.
  • Earnings quality in fiscal 2026 is high. Operating cash flow ($89.7B) exceeded net income ($85.0B), helped by $12.7B of customer deposits. Receivables rose to $36.2B from $9.3B a year earlier, which is about 65 days of fourth-quarter sales. Stock compensation was $1.33B (1.6% of net income). Inventory was $10.4B at year-end, and there have been no write-downs since fiscal 2023's $1.83B.
  • The value lens. New fabs committed at peak prices add industry supply in 2027–2030. In past cycles, peak-margin capex was what set up the next downturn, and we see no reason to assume this cycle breaks that pattern.

VI.Balance Sheet & Book Value

US$ millions28 Aug 202528 May 20263 Sep 2026*
Cash & equivalents9,64224,99538,364
Short- and long-term marketable investments2,2945,13335,089
Total debt14,5775,7225,179
Net cash / (net debt)(2,641)24,40668,274
Non-current customer contract liabilities (deposits)14256812,895
Receivables9,26531,02536,197
Inventories8,3558,56710,372
Property, plant & equipment46,59056,42663,310
Total equity54,165100,724138,378
  Per share (on 1,122M / 1,129M shares)$48.28$89.18$122.52
Source: balance sheets in the 30 Sep 2026 release (*unaudited) and the Q3 FY2026 10-Q. Excludes restricted cash (release total including restricted: $73.48B). Per-share figures use shares outstanding at the nearest cover date (Pathos calculation).

The balance sheet has been transformed within twelve months. Micron repaid $10.0B of debt in fiscal 2026, mostly ahead of maturity (booking $500M of prepayment losses in the first nine months), and net debt of $2.6B turned into $68.3B of net cash, or about $55B after deducting customer deposits. Book value per share rose from $48 to $123, almost all of it from retained fiscal 2026 earnings. Goodwill is only $1.15B, so tangible book is nearly the same.

Why book value matters here. For a capital-intensive, commodity-like business, book value (mostly fabs, equipment and cash) is a useful anchor across the cycle. At fiscal year-ends from 2015 to 2025, Micron's price-to-book ranged from 1.24× (FY2022) to 2.47× (FY2025), with a median of 1.74×. Applied to today's $122.52, that range implies $152–$302 per share (median $213). Today's 8.7× says the market is valuing Micron less like a memory manufacturer and more like a franchise with durable pricing power. That may prove right, but it is new, and it leaves no cushion if the cycle turns.

VII.Capital Allocation & Dilution

US$ millionsFY2022FY2023FY2024FY2025FY2026*
Share repurchases2,432425300—650
Dividends paid461504513522610
Stock-based compensation5145968339721,333
Repayments of debtMicron borrowed through the FY2023 downturn; total debt was $14.6B at FY2025 year-end10,043
Shares outstanding at year-end (M)1,0941,0981,1091,1221,129†
Source: 10-K XBRL data; *FY2026 release (unaudited). †10-Q cover count, 17 Jun 2026.
  • Modest dilution. Shares outstanding went from 1,084M (FY2015) to 1,129M (June 2026), up 4% in about eleven years, after cumulative buybacks. Stock compensation of $1.3B a year is small relative to current earnings but meaningful in a down-cycle.
  • Priorities in the boom: deleverage, then build. Fiscal 2026 cash went mainly into capex ($30.7B), debt reduction ($10.0B) and cash and investments (+$61.5B). Buybacks were small ($650M) and the $0.15 quarterly dividend is unchanged, so the payout ratio is under 1%. About $2.16B was left under the $10B repurchase authorization at 28 May 2026, and repurchases are subject to CHIPS Act restrictions.
  • The value question is what Micron does with ~$60B+ of annual free cash if the cycle holds. Buying back stock at 6.3× book would destroy value if earnings later revert. Holding cash through the cycle, as it is doing now, is the conservative choice.

VIII.Five-Year P/E Projection (Illustrative)

Read this firstThis is Pathos's illustrative projection of what analysts' earnings estimates and our stated assumptions imply for a five-year value, and what return that value implies from today's price. It is educational. It is not a price target and not a recommendation. Each input below is labelled as a reported or published figure, a calculation, or a Pathos assumption.
Evidence: Weak–moderateConsensus EPS is moderately well supported (36 analysts), but the mid-cycle share of peak earnings is a judgement. Years 1–2 are published analyst consensus; everything after that, and the exit multiple, are Pathos assumptions. How we grade evidence.

Method. We take fiscal 2027 and fiscal 2028 consensus EPS as Years 1 and 2 in every scenario, then apply a mid-cycle Year-5 EPS, set as a stated share of the fiscal 2028 consensus (memory earnings are cyclical and near a record), and an exit P/E to Year-5 (fiscal 2031) EPS. The bear and bull cases are the low and high ends of our best-estimate assumptions; the base case is the midpoint. Year-5 value = exit P/E × Year-5 EPS, and present value = Year-5 value ÷ 1.105. Only then do we bring in today's price, to show the implied annual return = (Year-5 value ÷ price)1/5 − 1. A price move changes the implied return, not the value; the values change when consensus or the stated assumptions do.

InputValueType and basis
Share price$778.31Source: Nasdaq close, 13 Nov 2026
Year 0: FY2026 EPS$75.52 non-GAAP
$74.33 GAAP
Source: company results (Section XIV). Non-GAAP shown because consensus is on that basis
Trailing P/E10.3×
10.5× GAAP
Calculation: price ÷ FY2026 EPS. Shown for reference, not applied
Year 1: FY2027 consensus EPS$176.50Source: Yahoo Finance, 36 analysts (range $161.00–$214.70), 15 Nov 2026
Year 2: FY2028 consensus EPS$207.76Source: Yahoo Finance, 36 analysts (range $136.00–$335.50); +17.7% on Year 1
Today's forward P/E (context only)4.4×Calculation: price ÷ Year-1 consensus EPS (the fiscal year already under way). Not used for the Year-5 value
Analysts' 5-year EPS growth (context)42.4% a yearSource: Finviz "EPS next 5Y", 31 Oct 2026. Not used directly
Diluted EPS growth, FY2015–FY202511.9% a yearCalculation from 10-K data: $2.47 → $7.59 across two full cycles
Mid-cycle Year-5 EPS, share of Year 2Bear 40% · Base 50% · Bull 60%Assumption: Mid-cycle EPS of 40–60% of the FY2028 consensus: past mid-cycle earnings were roughly 30–50% of peak, and HBM plus multi-year customer agreements justify a higher share.
Exit P/E on Year-5 EPSBear 10.0× · Base 11.8× · Bull 14.0×Assumption: 10–14× on normalised (not peak) earnings, bracketing Micron's own 12.9× 10-year median. Base = midpoint
Required return (present value)10% a yearAssumption
"Source" rows are reported or published figures; "Calculation" rows are derived from them; "Assumption" rows are Pathos choices (rule v35, set 15 Oct 2026, reviewed about once a year). Consensus EPS is likely non-GAAP.

How the range is built. Earnings. Memory earnings are cyclical and fiscal 2028 consensus is near a record, so we do not grow it. Instead Year-5 EPS is a mid-cycle level. Mid-cycle EPS of 40–60% of the FY2028 consensus: past mid-cycle earnings were roughly 30–50% of peak, and HBM plus multi-year customer agreements justify a higher share. That puts Year-5 EPS at $83.10 (bear) to $124.66 (bull), against $207.76 in fiscal 2028. Exit multiple. 10–14× on normalised (not peak) earnings, bracketing Micron's own 12.9× 10-year median. The base case is the midpoint of that range: its implied annual return is exactly halfway between the bear and bull returns, and its exit multiple is the midpoint of the two multiples (base growth is solved to match). None of these values uses today's price: the price enters only the implied return, so a price move changes the return, not the value. For context, the shares trade at 4.4× the current-year consensus today.

Year-by-year EPS

US$ per shareY0
FY2026A
Y1
FY2027E
Y2
FY2028E
Y3
FY2029E
Y4
FY2030E
Y5
FY2031E
Bear EPS$75.52$176.50$207.76$153.08$112.79$83.10
Base EPS$75.52$176.50$207.76$164.53$130.30$103.19
Bull EPS$75.52$176.50$207.76$175.23$147.80$124.66
  Growth, Years 1–2 (consensus)+134%+18%
  Year-5 EPS as share of Year 2Bear 40% · Base 50% · Bull 60%
Year 0 is reported. Years 1–2 are analyst consensus and are the same in every scenario. Years 3–5 move evenly (in % terms) from the Year-2 consensus to each scenario's mid-cycle Year-5 EPS (Pathos assumption). Source: model/pe_projection.py.

Year-5 value and implied return

US$BearBaseBull
Year-5 EPS, share of Year 240%50%60%
Year-5 EPS (FY2031)$83.10$103.19$124.66
Exit P/E10.0×11.8×14.0×
Year-5 value$831$1,221$1,745
vs. today's price of $778.31+7%+57%+124%
Implied annual return (5-yr CAGR)+1.3%+9.4%+17.5%
Present value at 10% a year$516$758$1,084
Present value vs. today's price−34%−3%+39%
Year-5 value = exit P/E × Year-5 (fiscal 2031) EPS, treated as a value about five years from now. Base = midpoint of the range (its return is the average of the bear and bull returns). Present value = Year-5 value ÷ 1.105. Today's price is used only for the implied return and the comparisons with price. Returns exclude dividends.

IX.Return vs. Today's Price

$600$800$1,000$1,200$1,400$1,600$1,800$2,000 Today $778.31 Base PV at 10%: $758 Bear $831 Base $1,221 Bull $1,745 +1.3%/yr+9.4%/yr+17.5%/yr

Pathos illustrative Year-5 (fiscal 2031) value range (bear–bull ends of our assumptions, base = midpoint), with each scenario's implied annual return from today's price. Red line: today's price. Dashed green line: the base-case Year-5 value discounted at 10% a year.

At $778.31 the base case implies about +9.4% a year over five years (+1.3% bear, +17.5% bull), before any dividend. Discounted at a 10% required return, the base Year-5 value is worth $758 today, −3% versus the price. Put the other way: at the base exit P/E of 11.8×, a 10% annual return needs Year-5 EPS of about $105.94; EPS could fall about 20.1% a year in Years 3–5 and still deliver it. Evidence grade: Weak–moderate.

X.Superinvestor Holders (Dataroma)

Which of the portfolio managers that Dataroma tracks own MU, according to their latest 13F filings? The figures below come only from Dataroma’s MU ownership page and activity page.

Source: Dataroma · retrieved 15 Nov 2026 · 13F period Q2 2026 (holdings at 30 Jun 2026)
Superinvestors holding5Dataroma ownership count
Ownership rank155Dataroma rank by ownership count
% of all portfolios0.184%Dataroma measure
Hold price$1,154.29Close at 30 Jun 2026

The table shows 1 of the 5 Dataroma-tracked holders: the only one with more than 5% of their portfolio in MU.

Superinvestor% of portfolioSharesValue (US$m)Recent activity13F period
David Tepper - Appaloosa Management15.06%975,0001,125.4Reduce 41.44%Q2 2026
Source: Dataroma, retrieved 15 Nov 2026. Holders with more than 5% of their portfolio, sorted by value. Value is Dataroma’s figure at 30 Jun 2026, shown in US$ millions.

Dataroma shows 5 tracked superinvestors with a position at 30 Jun 2026. The largest weight belongs to David Tepper - Appaloosa Management, at 15.06% of the manager’s reported portfolio.

Reading 13F dataDataroma compiles the quarterly Form 13F filings of a group of portfolio managers it selects as “superinvestors”; this section shows only those managers, and no other holders. 13F reports are filed up to 45 days after quarter-end, so these are positions as of 30 Jun 2026 (Q2 2026) and may have changed since; managers that have already filed for Q3 2026 (holdings at 30 Sep 2026) are labelled Q3 2026 in the table. They cover only long positions in US-listed securities; they omit short positions, most non-US holdings, cash and bonds. “% of portfolio” is the position as a share of that manager’s reported 13F portfolio. “Recent activity” is the change in share count during the latest quarter; “No change” means Dataroma shows no change for that quarter. Dataroma’s “hold price” is the closing price at the portfolio date, not today’s price. Superinvestor ownership is context, not a reason to buy or sell.

XI.Key Risks for Value Investors

1

The cycle turns

Memory prices are set by industry supply and demand, and Micron's history shows how fast profits reverse:

  • FY2016: Revenue −23% and operating margin 1.4%. Free cash flow −$2.6B.
  • FY2018: Prior-cycle peak: operating margin 49.3%, EPS $11.51.
  • FY2019–FY2020: Revenue fell 23%, then another 8%. EPS dropped to $2.37.
  • FY2023: Revenue −49.5%, gross margin −9.1%, operating margin −37.0%, a $1.83B inventory write-down and a $5.8B net loss. Debt roughly doubled.
  • FY2026: AI-driven upcycle: operating margin 74.6%, EPS $74.33 (unaudited).
2

Supply response

High margins attract capacity. Micron itself is adding fabs in Idaho, New York, Taiwan and Singapore, with output from 2027. CNBC reports that SK hynix and Samsung are building large new HBM fabs, and Micron's filings flag state-supported Chinese competitors (CXMT, YMTC) and the risk of "DRAM and NAND oversupply". HBM also uses much more wafer area per bit, and if HBM demand slows that capacity can flood conventional DRAM.

3

Contract terms are only partly disclosed

The Strategic Customer Agreements are take-or-pay with floors, but the largest also carry ceilings near second-quarter 2026 prices, which caps upside. A minority float with market prices. Volumes, durations, counterparties and what happens if a customer cannot perform are not disclosed. Deposits ($12.9B) are real cash, but they are also an obligation to deliver.

4

Execution, technology and capex

HBM yields, HBM4/HBM4E qualification and new EUV nodes are hard, and the filings cite yield barriers in multi-layer HBM stacks. Capex above $43B in fiscal 2027 raises the fixed-cost base. CHIPS Act grants carry conditions, including buyback restrictions, and can be clawed back.

5

Customer and end-market concentration

The top ten customers are about half of revenue, and one was 17% in fiscal 2025. Roughly half of revenue is data center, tying Micron to hyperscaler and AI-accelerator spending plans.

6

Geopolitics and trade

Since 2023 China's Cyberspace Administration has barred critical-infrastructure operators there from buying Micron products. Manufacturing is concentrated in Taiwan, Japan, Singapore and the U.S., and export controls, tariffs and retaliation are recurring risk factors.

7

Litigation

In May 2024 a jury awarded Netlist $445M over memory-module patents. Micron is appealing, and the USPTO's patent board has found the main asserted claim unpatentable. Further Netlist suits target HBM products, and YMTC has filed multiple patent suits in the U.S. and China.

8

Data and timing

FY2026 figures are unaudited until the 10-K is filed (last year's came on 3 Oct 2025). Our price predates the results, and the stock moved between about $1,040 and $1,078 after hours on 30 September.

XII.Advice to Management

Pathos's long-term owner principles judge management by the per-share value it builds over many years, not by quarterly results. Applied to Micron's figures in this note, we would offer the following recommendations.

1

Do not buy back stock at peak-cycle valuations

The shares trade at 8.7× book value, against a range of 1.2× to 2.5× at fiscal year-ends from 2015 to 2025, and about $2.16 billion remains under the repurchase authorization. Repurchases at a price that assumes peak earnings will last would transfer value to departing shareholders. We would hold off now and buy aggressively in the next downturn, when the stock trades closer to book value.

2

Keep the cash for the down-cycle

Micron turned $2.6 billion of net debt into $68.3 billion of net cash in fiscal 2026 (about $55 billion after customer deposits). Its operating margin was −37% as recently as fiscal 2023. We would set an explicit minimum cash reserve sized to fund planned capex through a severe downturn without new borrowing, and only treat cash above that level as surplus.

3

Add capacity against commitments, not prices

Management's guidance implies more than $43 billion of net capex in fiscal 2027, across new fabs in Idaho, New York, Taiwan and Singapore. Memory history shows that capacity added in a shortage tends to arrive when prices are falling. We would tie major capacity decisions to customer commitments such as the $12.9 billion of long-term deposits, and report the expected return on each incremental investment.

4

Report through-cycle economics alongside peak results

From fiscal 2015 to 2025 Micron converted $48.9 billion of net income into only $15.2 billion of free cash flow because capex averaged 36.6% of revenue. Fiscal 2026's $85.0 billion of net income is not a normal year. We would publish through-cycle measures (average margins, free cash flow and capex versus depreciation) so owners do not extrapolate the peak.

5

Pay for returns on capital across the cycle

Stock compensation of $1.3 billion a year is small next to current earnings but meaningful in a downturn. Incentives tied to a single year's EPS reward the cycle rather than management. We would base long-term pay on multi-year return on invested capital and per-share value, measured over a full cycle.

Opinion, not advice. These recommendations are Pathos's opinion, based on long-term owner principles and the figures in this note; they are not investment advice.

XIII.Conclusion

The case for. Micron is a technology leader in the scarcest input to AI systems. It has turned a net-debt balance sheet into $68B of net cash in a year, generates more than $60B of annual free cash, and has locked in multi-year take-or-pay contracts with price floors that management says will produce margins above any past-cycle peak even at the floor. On forward earnings it trades at under 7×.

The case against. Those forward earnings come from the top of a record cycle in a commodity industry. Over eleven years Micron converted less than a third of its earnings into free cash because of the capex required. The stock trades at 6.3× book against a historical range of 1.2–2.5×, and it is up more than 250% in a year. The contracts reduce the risk of a collapse but do not remove it, and their terms are largely undisclosed. Industry capacity, including Micron's own, is growing quickly.

Pathos view (illustrative). On our best-estimate assumptions the base case implies about +9.4% a year (Year-5 range $831–$1,745) and is worth about $758 today at a 10% required return. Evidence: Weak–moderate. Consensus EPS is moderately well supported (36 analysts), but the mid-cycle share of peak earnings is a judgement. Points worth watching: (a) new industry capacity arriving in 2028–29 and prices falling, (b) hyperscaler capex digestion, (c) losing share in next-generation HBM. This is an educational illustration, not a recommendation to buy, sell or hold.

XIV.Sources & Notes

As-of dates. Share price, market capitalisation and all price-based multiples use the Nasdaq closing price of $778.31 on 13 November 2026. The 52-week range, consensus estimates and beta are as retrieved from Yahoo Finance on 15 November 2026. FY2026 fundamentals are from the Q4 FY2026 earnings release (fiscal year ended 3 September 2026; full-year revenue and EPS match the 10-K filed 9 October 2026), and earlier years are from audited 10-K data. The analysts' long-term growth estimate is from Finviz, retrieved 30 September 2026. Ratios, free cash flow, historical price-to-book and all projection outputs are Pathos calculations.

  1. Micron Technology, Inc., "Micron Technology, Inc. Reports Record Fiscal Fourth-Quarter and Full-Year 2026 Results", Exhibit 99.1 to Form 8-K (30 Sep 2026): FY2026 and Q4 results, balance sheet, cash flows, business-unit revenue, Q1 FY2027 guidance, dividend.
  2. Form 10-Q for the quarter ended 28 May 2026 (filed 25 Jun 2026): Strategic Customer Agreements, expected deposits, capex estimate, CHIPS Act and fab plans, repurchase authorization, DRAM/NAND revenue, litigation, cover share count.
  3. Forms 10-Q for the quarters ended 27 Nov 2025 and 26 Feb 2026: Q1 and Q2 FY2026 results.
  4. Form 10-K for fiscal year ended 28 Aug 2025 (filed 3 Oct 2025): business description, HBM products, competitors, customer concentration, employees, FY2023–FY2025 figures.
  5. SEC EDGAR XBRL company facts for CIK 723125: FY2015–FY2025 income statement, cash flow, equity, share counts, buybacks, dividends, stock compensation and inventory write-downs.
  6. Form 8-K, 26 Aug 2026: appointment of Manish Bhatia (President & COO) and Scott DeBoer (President & CTPO). Form 8-K, 25 Mar 2026: debt tender offers.
  7. Yahoo Finance, MU price history and analyst estimates (retrieved 15 Nov 2026): 13 Nov 2026 close, 52-week range, month-end closes used for historical price-to-book, FY2027 consensus EPS $161.49 (36 analysts) and FY2028 $181.98 (24 analysts), quarterly non-GAAP EPS history (Q1 FY2026 $4.78), FY2027 revenue consensus, mean target $1,520.76 (46 analysts), beta 2.22.
  8. CNBC, "Micron beats on earnings and issues strong guidance as global memory shortage continues" (30 Sep 2026): LSEG consensus, only U.S.-based HBM maker, relative HBM share, one-year stock performance.
  9. FXStreet, "Micron impresses with $54.2 billion in Q4 revenue" (30 Sep 2026): corroborates the ~$1,065 close and the after-hours range of ~$1,040–1,078.
  10. Finviz, MU quote and statistics (retrieved 31 Oct 2026): analysts' five-year EPS growth estimate ("EPS next 5Y", 42.36% a year).
  11. StockAnalysis, MU forecast (retrieved 15 Oct 2026; data from S&P Global Market Intelligence): corroborates the 30 Sep 2026 close.
  12. Roic AI, Micron Q3 FY2026 earnings call transcript (24 Jun 2026): HBM4 revenue above $1B, FY2027 capex and opex commentary (third-party transcript).
  13. SEC XBRL company facts (SEC EDGAR XBRL API, retrieved 15 Nov 2026): quarterly revenue, net income and diluted EPS from Forms 10-Q and 10-K (fiscal Q4 derived as full year minus nine months), and quarter-end equity, goodwill, intangible assets, preferred stock and shares outstanding. Used for the quarterly charts in Section IV.
  14. Yahoo Finance, MU daily price history (retrieved 15 Nov 2026): split-adjusted quarter-end closing prices for the trailing P/E line.
  15. Dataroma, MU superinvestor ownership page and activity page (retrieved 15 Nov 2026): ownership count, rank, % of all portfolios, hold price, holders, % of portfolio, shares, value and recent activity for 13F period Q2 2026 (holdings at 30 Jun 2026). 13F data are filed up to 45 days after quarter-end and cover long US-listed positions only.

Not verified or not used: the line-by-line reconciliation of the release to the audited FY2026 10-K (filed 9 Oct 2026; full-year revenue and EPS checked); a formal FY2027 capex figure (only the qualitative quarterly comment); total HBM revenue and market share (not disclosed); the terms, counterparties and total value of the Strategic Customer Agreements concluded after 28 May 2026; the date of the 52-week low; diluted share count at 3 Sep 2026 beyond the ~1.15B guidance; post-earnings trading on 1 Oct 2026. The consensus EPS figures were compiled before the Q4 release and are likely non-GAAP. Analysts' five-year growth estimates come from a single aggregator (Finviz) and are not audited. The P/E projection's calculations are kept with the site files (model/pe_projection.py) for audit.

Not investment advice. This research note is general information for educational purposes only. It is not investment, legal, tax or accounting advice, and it does not recommend buying, selling or holding any security. The valuation figures are Pathos Investments' illustrative estimates, based on the stated assumptions, and may be materially wrong. Figures come from the sources listed, which may contain errors or be revised; Micron's FY2026 figures are unaudited. Prices and facts change after the stated dates. Pathos Investments is not a registered investment adviser or broker-dealer. Do your own research and consider consulting a licensed professional before making investment decisions.